<DOC>
	<DOCNO>NCT01091961</DOCNO>
	<brief_summary>Patients stable dose ACE inhibitor ARB medication schedule elective surgery randomize take ACE inhibitor ARB include morning surgery , hold day prior surgery . The patient follow 30 day surgery assess adverse health outcome .</brief_summary>
	<brief_title>Study Preoperative Management Angiotensin Converting Enzyme Inhibitor ( ACEi ) Angiotensin Receptor Blocker ( ARB ) Medications</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Enzyme Inhibitors</mesh_term>
	<mesh_term>Angiotensin-Converting Enzyme Inhibitors</mesh_term>
	<mesh_term>Angiotensin II Type 1 Receptor Blockers</mesh_term>
	<mesh_term>Angiotensin Receptor Antagonists</mesh_term>
	<criteria>currently take ACEi , ARB change medication two week prior study enrollment schedule noncardiac surgery require regional general anesthesia minimum overnight anticipated length stay age ≥18 year . explicit instruction provide patient surgical team regard perioperative management ACEi ARB significant hypertension preoperative assessment clinic ( systolic blood pressure ≥180 mmHg OR diastolic blood pressure ≥110 mmHg ) significant hypotension preoperative assessment clinic ( systolic blood pressure &lt; 90 mmHg ) prior enrollment study participation another research study antihypertensive medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>ACE inhibitor</keyword>
	<keyword>ARB</keyword>
	<keyword>Non-cardiac surgery</keyword>
	<keyword>Perioperative</keyword>
	<keyword>Preoperative</keyword>
	<keyword>Hypotension</keyword>
	<keyword>Congestive heart failure</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Angiotensin-Converting Enzyme Inhibitors</keyword>
	<keyword>Angiotensin II Type 1 Receptor Blockers</keyword>
	<keyword>Perioperative Care</keyword>
</DOC>